Pro-inflammatory conditions promote neuronal damage mediated by Amyloid Precursor Protein and decrease its phagocytosis and degradation by microglial cells in culture.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Neurobiology of Disease

• Publication date

  2007-04-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.NBD.2006.12.006PMID 17240154
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Amyloid precursor protein‐mediated free radicals and oxidative damage: Implications for the development and progression of Alzheimer's disease

  2006cited by this paper
• Neuroprotective properties of the innate immune system and bone marrow stem cells in Alzheimer's disease

  2006cited by this paper
• Inflammation in Alzheimer disease: driving force, bystander or beneficial response?

  2006cited by this paper
• A Medical Mystery — Gangrene and Cutaneous Nodules

  2006cited by this paper
• Progressive neuronal loss and behavioral impairments of transgenic C57BL/6 inbred mice expressing the carboxy terminus of amyloid precursor protein.

  2006cited by this paper
• Minocycline affects microglia activation, Aβ deposition, and behavior in APP‐tg mice

  2006cited by this paper
• A key role for the microglial NADPH oxidase in APP-dependent killing of neurons.

  2006cited by this paper
• Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice.

  2005cited by this paper
• Expression of Scavenger Receptors in Glial Cells

  2005cited by this paper
• Microglia and neuroprotection: implications for Alzheimer's disease.

  2005cited by this paper
• Protection of rat primary hippocampal cultures from A beta cytotoxicity by pro-inflammatory molecules is mediated by astrocytes.

  2005cited by this paper
• Transforming growth factor-beta 1 produced by hippocampal cells modulates microglial reactivity in culture.

  2005cited by this paper
• Decline of immune responsiveness: a pathogenetic factor in Alzheimer's disease?

  2005cited by this paper
• Pathophysiological roles of amyloidogenic carboxy-terminal fragments of the beta-amyloid precursor protein in Alzheimer's disease.

  2005cited by this paper
• The complex of microglial cells and amyloid star in three-dimensional reconstruction

  2004cited by this paper
• Free radicals and aging.

  2004cited by this paper
• Cytokines and the aging brain - what we don't know might help us.

  2004cited by this paper
• Free radicals: key to brain aging and heme oxygenase as a cellular response to oxidative stress.

  2004cited by this paper
• The effect of oxidative stress on amyloid precursor protein processing in cells engaged in β-amyloidosis is related to apolipoprotein E genotype

  2004cited by this paper
• Time-dependent reduction in Aβ levels after intracranial LPS administration in APP transgenic mice

  2004cited by this paper
• Cells of monocyte/microglial lineage are involved in both microvessel amyloidosis and fibrillar plaque formation in APPsw tg mice.

  2004cited by this paper
• Microglial reactivity to beta-amyloid is modulated by astrocytes and proinflammatory factors.

  2004cited by this paper
• Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonists modulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase.

  2003cited by this paper
• Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease.

  2003cited by this paper
• Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid beta peptide in APPswe transgenic mice.

  2003cited by this paper
• Anti-Inflammatory Drug Therapy Alters β-Amyloid Processing and Deposition in an Animal Model of Alzheimer's Disease

  2003cited by this paper
• Accumulation of caspase cleaved amyloid precursor protein represents an early neurodegenerative event in aging and in Alzheimer's disease.

  2003cited by this paper
• Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report

  2003cited by this paper
• Slow Cognitive Decline in Alzheimer’s Disease

  2003cited by this paper
• Nonsteroidal Anti-Inflammatory Drugs and Peroxisome Proliferator-Activated Receptor-γ Agonists Modulate Immunostimulated Processing of Amyloid Precursor Protein through Regulation of β-Secretase

  2003cited by this paper
• The Role of the Carboxyl‐Terminal Fragments of Amyloid Precursor Protein in Alzheimer's Disease

  2002cited by this paper
• Microglia and inflammatory mechanisms in the clearance of amyloid β peptide

  2002cited by this paper
• Randomized pilot study of nimesulide treatment in Alzheimer’s disease

  2002cited by this paper
• Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide.

  2002cited by this paper
• Immune response gene expression increases in the aging murine hippocampus.

  2002cited by this paper
• Immobilized amyloid precursor protein constructs: a tool for the in vitro screening of glial cell reactivity

  2001cited by this paper
• Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case-control study.

  2001cited by this paper
• Microglia-astrocyte interaction in Alzheimer's disease: friends or foes for the nervous system?

  2001cited by this paper
• Interleukin-1β Promotes Repair of the CNS

  2001cited by this paper
• Effects of the β-Amyloid and Carboxyl-terminal Fragment of Alzheimer's Amyloid Precursor Protein on the Production of the Tumor Necrosis Factor-α and Matrix Metalloproteinase-9 by Human Monocytic THP-1*

  2001cited by this paper
• Ibuprofen decreases cytokine-induced amyloid beta production in neuronal cells.

  2001cited by this paper
• Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease.

  2001cited by this paper
• Interleukin-1beta promotes repair of the CNS.

  2001cited by this paper
• Effects of the carboxyl‐terminal fragment of Alzheimer's amyloid precursor protein and amyloid β ‐peptide on the production of cytokines and nitric oxide in glial cells

  2001cited by this paper
• Effect of hydroxychloroquine on progression of dementia in early Alzheimer's disease: an 18-month randomised, double-blind, placebo-controlled study.

  2001cited by this paper
• Amyloid beta vaccination: reduced plaques and improved cognition.

  2001cited by this paper
• Amyloid β vaccination: reduced plaques and improved cognition

  2001cited by this paper
• Polymorphisms in inflammatory genes and the risk of Alzheimer disease.

  2001cited by this paper
• Association of early‐onset Alzheimer's disease with an interleukin‐1α gene polymorphism

  2000cited by this paper
• A second cytotoxic proteolytic peptide derived from amyloid β-protein precursor

  2000cited by this paper
• Inflammation and Alzheimer's disease.

  2000cited by this paper
• A randomized controlled trial of prednisone in Alzheimer’s disease

  2000cited by this paper
• Carboxyl‐terminal fragment of Alzheimer's APP destabilizes calcium homeostasis and renders neuronal cells vulnerable to excitotoxicity

  2000cited by this paper
• Autotoxicity and Alzheimer disease.

  2000cited by this paper
• Association of an interleukin 1 alpha polymorphism with Alzheimer's disease.

  2000cited by this paper
• APP carboxyl‐terminal fragment without or with Aβ domain equally induces cytotoxicity in differentiated PC12 cells and cortical neurons

  2000cited by this paper
• Proteolytic processing and cell biological functions of the amyloid precursor protein.

  2000cited by this paper
• Fear recognition deficits after focal brain damage

  2000cited by this paper
• Confirmation of the genetic association of interleukin-1A with early onset sporadic Alzheimer's disease.

  2000cited by this paper
• Anti-inflammatory drugs protect against Alzheimer disease at low doses.

  2000cited by this paper
• Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

  2000cited by this paper
• Identification of β-secretase-like activity using a mass spectrometry-based assay system

  2000cited by this paper
• Gene polymorphism affecting α1‐antichymotrypsin and interleukin‐1 plasma levels increases Alzheimer's disease risk

  2000cited by this paper
• A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor.

  2000cited by this paper
• Association of a haplotype for tumor necrosis factor in siblings with late-onset Alzheimer disease: the NIMH Alzheimer Disease Genetics Initiative.

  2000cited by this paper
• Association of interleukin‐1 gene polymorphisms with Alzheimer's disease

  2000cited by this paper
• Polymorphisms of the IL-6 gene increase the risk for late onset Alzheimer's disease and affected IL-6 plasma levels

  2000cited by this paper
• Association of an interleukin 1α polymorphism with Alzheimer’s disease

  2000cited by this paper
• Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse

  1999cited by this paper
• TNFalpha plus IFNgamma induce the production of Alzheimer beta-amyloid peptides and decrease the secretion of APPs.

  1999cited by this paper
• A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer’s disease

  1999cited by this paper
• Increased interleukin-6 expression by microglia from brain of aged mice.

  1999cited by this paper
• A genetic variation of the inflammatory cytokine interleukin‐6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease

  1999cited by this paper
• Toxicity of human THP-1 monocytic cells towards neuron-like cells is reduced by non-steroidal anti-inflammatory drugs (NSAIDs).

  1999cited by this paper
• Translation of the Alzheimer Amyloid Precursor Protein mRNA Is Up-regulated by Interleukin-1 through 5′-Untranslated Region Sequences*

  1999cited by this paper
• TNFα plus IFNγ induce the production of Alzheimer β‐amyloid peptides and decrease the secretion of APPs

  1999cited by this paper
• Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF.

  1998cited by this paper
• The free radical theory of aging matures.

  1998cited by this paper
• Cytotoxic Amyloid Peptides Inhibit Cellular 3‐(4,5‐Dimethylthiazol‐2‐yl)‐2,5‐Diphenyltetrazolium Bromide (MTT) Reduction by Enhancing MTT Formazan Exocytosis

  1997cited by this paper
• Processing of Amyloid Precursor Protein in Human Primary Neuron and Astrocyte Cultures

  1997cited by this paper
• Effects of acidosis on the distribution of processing of the beta-amyloid precursor protein in cultured hippocampal neurons.

  1997cited by this paper
• Microglial activation in early stages of amyloid β protein deposition

  1997cited by this paper
• Microglial activation in early stages of amyloid beta protein deposition.

  1997cited by this paper
• Risk of Alzheimer's disease and duration of NSAID use

  1997cited by this paper
• Slow Degradation of Aggregates of the Alzheimer’s Disease Amyloid β-Protein by Microglial Cells*

  1997cited by this paper
• Immunosuppressive effects of apoptotic cells

  1997cited by this paper
• Effect of energy shortage and oxidative stress on amyloid precursor protein metabolism in COS cells.

  1997cited by this paper
• Mechanism of Cellular 3‐(4,5‐Dimethylthiazol‐2‐yl)‐2,5‐Diphenyltetrazolium Bromide (MTT) Reduction

  1997cited by this paper
• Effects of acidosis on the distribution and processing of the β-amyloid precursor protein in cultured hippocampal neurons

  1997cited by this paper
• Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E

  1997cited by this paper
• Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils

  1996cited by this paper
• Granules in glial cells of patients with Alzheimer's disease are immunopositive for C-terminal sequences of β-amyloid protein ☆

  1996cited by this paper
• Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor.

  1996cited by this paper
• Enhanced Release of Amyloid -Protein from Codon 670/671 Swedish Mutant -Amyloid Precursor Protein Occurs in Both Secretory and Endocytic Pathways (*)

  1996cited by this paper
• Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils.

  1996cited by this paper
• Granules in glial cells of patients with Alzheimer's disease are immunopositive for C-terminal sequences of beta-amyloid protein.

  1996cited by this paper
• Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease

  1996cited by this paper
• Microglial Cells Internalize Aggregates of the Alzheimer's Disease Amyloid β-Protein Via a Scavenger Receptor

  1996cited by this paper
• Amyloid beta protein (A beta) removal by neuroglial cells in culture.

  1995cited by this paper
• The lysosomal cysteine protease, cathepsin S, is increased in Alzheimer's disease and Down syndrome brain. An immunocytochemical study.

  1995cited by this paper

• Microglial reactivity in brainstem chemosensory nuclei in response to hypercapnia

  2024influential citation
• Vagus nerve stimulation (VNS) preventing postoperative cognitive dysfunction (POCD): two potential mechanisms in cognitive function

  2024cites this paper
• Aging Microglia and Their Impact in the Nervous System.

  2024cites this paper
• Neuroinflammation: The central enabler of postoperative cognitive dysfunction.

  2023cites this paper
• Microglial Cell Dysregulation in the Aged Brain and Neurodegeneration

  2021cites this paper
• The CRISPR-Cas9 crATIC HeLa transcriptome: Characterization of a novel cellular model of ATIC deficiency and ZMP accumulation

  2020cites this paper
• A Network-Guided Reaction-Diffusion Model of AT[N] Biomarkers in Alzheimer’s Disease

  2020cites this paper
• [Quercetin ameliorates inflammation in CA1 hippocampal region in aged triple transgenic Alzheimer´s disease mice model.]

  2017cites this paper
• Involvement of the Bradykinin B1 Receptor in Microglial Activation: In Vitro and In Vivo Studies

  2017cites this paper
• Origanum Vulgare L. Extracts Versus Thymol: An Anti‐Inflammatory Study on Activated Microglial and Mixed Glial Cells

  2016cites this paper
• Recent Updates on the Association Between Alzheimer's Disease and Vascular Dementia.

  2016cites this paper
• Microglia in Glia–Neuron Co-cultures Exhibit Robust Phagocytic Activity Without Concomitant Inflammation or Cytotoxicity

  2015cites this paper
• Role of TGFβ signaling in the pathogenesis of Alzheimer’s disease

  2015influential citation
• Effect of novel quercetin pivaloyl ester on functions of adult rat microglia

  2015cites this paper
• Magnesium Lithospermate B Protects Neurons Against Amyloid β (1–42)-Induced Neurotoxicity Through the NF-κB Pathway

  2015cites this paper
• Ejercicio y envejecimiento: cambios transcripcionales y epigenéticos en un modelo murino de envejecimiento acelerado

  2015cites this paper
• Chronic exposure to TGFβ1 regulates myeloid cell inflammatory response in an IRF7‐dependent manner

  2014cites this paper
• Evaluación de especies de Agave sobre los procesos fisiopatológicos asociados al Alzheimer.

  2014cites this paper
• Role of Scavenger Receptors in Glia-Mediated Neuroinflammatory Response Associated with Alzheimer's Disease

  2013cites this paper
• Neuroinflammation is a generally beneficial process mediated by the activation of glial cells in response to injury, illness, or infection. Astrocytes and microglia release inflammatory mediators like cytokines and radical species like nitric oxide (NOÆ) and superoxide anion (O2Æ

  2012cites this paper
• Aβ Potentiates Inflammatory Activation of Glial Cells Induced by Scavenger Receptor Ligands and Inflammatory Mediators in Culture

  2012cites this paper
• Transforming growth factor‐β stimulates β amyloid uptake by microglia through Smad3‐dependent mechanisms

  2012cites this paper
• Glial hemichannels and their involvement in aging and neurodegenerative diseases

  2012cites this paper
• Cerebrovascular Disorders: Role of Aging

  2012cites this paper
• Scavenger receptor class A ligands induce secretion of IL1β and exert a modulatory effect on the inflammatory activation of astrocytes in culture.

  2012cites this paper
• Modulation of interferon‐γ‐induced glial cell activation by transforming growth factor β1: A role for STAT1 and MAPK pathways

  2012cites this paper
• Alzheimer's disease: redox dysregulation as a common denominator for diverse pathogenic mechanisms.

  2012cites this paper
• Acceleration of age-related learning and memory decline in middle-aged CD-1 mice due to maternal exposure to lipopolysaccharide during late pregnancy.

  2011cites this paper
• S-propargyl-cysteine, a novel hydrogen sulfide-modulated agent, attenuates lipopolysaccharide-induced spatial learning and memory impairment: involvement of TNF signaling and NF-κB pathway in rats.

  2011cites this paper
• Cross talk between activation of microglia and astrocytes in pathological conditions in the central nervous system.

  2011cites this paper
• γ‐Secretase component presenilin is important for microglia β‐amyloid clearance

  2011cites this paper
• Non-cholinergic pharmacotherapy approaches to Alzheimer's disease: the use of non-steroidal anti-inflammatory drugs.

  2011cites this paper
• Neurobiology of Vascular Dementia

  2011cites this paper
• Proliferating culture of aged microglia for the study of neurodegenerative diseases.

  2011cites this paper
• Microglial activation depends on beta‐amyloid conformation: role of the formylpeptide receptor 2

  2010cites this paper
• The neuroinflammatory hypothesis of delirium

  2010cites this paper
• of Alzheimer ’ s Disease Neuroinflammation , AD , and Dementia

  2010cites this paper
• Resveratrol Attenuates Neuroinflammation-mediated Cognitive Deficits in Rats

  2010cites this paper
• Effects of Immunomodulatory Substances on Phagocytosis of Aβ 1–42 by Human Microglia

  2010influential citation
• Participation of Glial Cells in the Pathogenesis of AD: A Different View on Neuroinflammation

  2009cites this paper
• HIV-1 TAT inhibits microglial phagocytosis of Abeta peptide.

  2008cites this paper
• Proinflammatory Stimuli are Needed for Induction of Microglial Cell-Mediated AβPP244–C and Aβ-Neurotoxicity in Hippocampal Cultures

  2008cites this paper
• In search of a treatment for Alzheimer's disease and potential immunonosuppresive therapeutic interventions.

  2008cites this paper
• Inflammatory Aspects of Alzheimer Disease and Other Neurodegenerative Disorders

  2008cites this paper
• Original Article HIV-1 TAT Inhibits Microglial Phagocytosis of Aβ Peptide

  2008cites this paper
• Inflammation as a potential mediator for the association between periodontal disease and Alzheimer’s disease

  2008cites this paper
• CD45RB Is a Novel Molecular Therapeutic Target to Inhibit Aβ Peptide-Induced Microglial MAPK Activation

  2008cites this paper
• Diagnostic utility of APOE, soluble CD40, CD40L, and Abeta1-40 levels in plasma in Alzheimer's disease.

  2008cites this paper
• Glial cell dysregulation: a new perspective on Alzheimer disease

  2007cites this paper